Article
Primary histiocytic sarcoma of the central nervous system: a case report with platelet derived growth factor receptor mutation and PD-L1/PD-L2 expression and literature review.
Radiation oncology (London, England) - 5 Sept 2018
May Jackson M, Waddle Mark R, Miller Daniel H, Stross William C, Kaleem Tasneem A, May Byron C, Miller Robert C, Jiang Liuyan, Strong Gerald W, Trifiletti Daniel M, Chaichana Kaisorn L, Reimer Ronald, Tun Han W, Peterson Jennifer L
Abstract excerpt
BACKGROUND: Histiocytic sarcoma (HS) is an aggressive malignant neoplasm. HS in the central nervous system is exceptionally rare and associated with a poor prognosis. This report documents a case of primary HS of the central nervous system with treatment including surgery, radiotherapy, and chemotherapy. CASE PRESENTATION: Our patient was a 47 year old female presenting with progressive ataxia, headaches,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.